Histogenics Corporation Announces First Quarter 2016 Financial and Operating Results
May 12, 2016 06:30 ET
|
Histogenics Corporation
- NeoCart® Phase 3 Clinical Trial Remains on Track for Enrollment Completion by End of Second Quarter of 2017 - - Company to Host Conference Call and Webcast Today at 8:30 a.m. EDT - WALTHAM,...
Histogenics Corporation Acquires NeoCart® Development and Commercialization Rights for Japanese Market
May 10, 2016 09:00 ET
|
Histogenics Corporation
WALTHAM, Mass., May 10, 2016 (GLOBE NEWSWIRE) -- Histogenics Corporation (Histogenics) (Nasdaq:HSGX), a regenerative medicine company focused on developing and commercializing products in the...
Histogenics Corporation to Announce First Quarter 2016 Financial Results on May 12, 2016
April 28, 2016 08:30 ET
|
Histogenics Corporation
WALTHAM, Mass., April 28, 2016 (GLOBE NEWSWIRE) -- Histogenics Corporation (Nasdaq:HSGX), a regenerative medicine company focused on developing and commercializing products in the musculoskeletal...
Histogenics Corporation To Present At Needham & Company’s 15th Annual Healthcare Conference
March 31, 2016 08:30 ET
|
Histogenics Corporation
WALTHAM, Mass., March 31, 2016 (GLOBE NEWSWIRE) -- Histogenics Corporation (Histogenics) (Nasdaq:HSGX), a regenerative medicine company focused on developing and commercializing products in the...
Histogenics Corporation to Present at 4th Annual Cell & Gene Therapy Investor Day
March 14, 2016 08:30 ET
|
Histogenics Corporation
WALTHAM, Mass., March 14, 2016 (GLOBE NEWSWIRE) -- Histogenics Corporation (Histogenics) (Nasdaq:HSGX), a regenerative medicine company focused on developing and commercializing products in the...
Histogenics Corporation Announces Financial and Operating Results for the Fourth Quarter and Year Ended December 31, 2015
March 10, 2016 06:30 ET
|
Histogenics Corporation
- NeoCart® Phase 3 Clinical Trial More Than 50% Enrolled and on Track for Full Enrollment by End of Second Quarter of 2017 - - Company to Host Conference Call and Webcast Today at 8:30 a.m....
Histogenics Corporation Announces Presentation of Data at Orthopaedic Research Society (ORS) Annual Meeting
March 03, 2016 08:30 ET
|
Histogenics Corporation
WALTHAM, Mass., March 03, 2016 (GLOBE NEWSWIRE) -- Histogenics Corporation (Histogenics) (Nasdaq:HSGX), a regenerative medicine company focused on developing and commercializing products in the...
Histogenics Corporation to Announce 2015 Financial Results on March 10, 2016
March 01, 2016 08:30 ET
|
Histogenics Corporation
WALTHAM, Mass., March 01, 2016 (GLOBE NEWSWIRE) -- Histogenics Corporation (Nasdaq:HSGX), a regenerative medicine company focused on developing and commercializing products in the musculoskeletal...
Histogenics Corporation to Present at Upcoming Investor Conferences
February 25, 2016 08:30 ET
|
Histogenics Corporation
WALTHAM, Mass., Feb. 25, 2016 (GLOBE NEWSWIRE) -- Histogenics Corporation (Histogenics) (Nasdaq:HSGX), a regenerative medicine company focused on developing and commercializing products in the...
Histogenics Corporation Provides NeoCart® Phase 3 Clinical Trial Enrollment Update
February 02, 2016 16:05 ET
|
Histogenics Corporation
WALTHAM, Mass., Feb. 02, 2016 (GLOBE NEWSWIRE) -- Histogenics Corporation (Histogenics) (Nasdaq:HSGX), a regenerative medicine company focused on developing and commercializing products in the...